| DAVOQIS SUNOVION PHARMACEUTICALS INC.
1810405 21 Nov 2016 | on 22 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for treating central nervous system diseases and disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits and addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, and drug addiction, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse and respiratory system diseases and disorders, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease and respiratory system diseases and disorders | |